Cytotoxin CctA, a major virulence factor of Clostridium chauvoei conferring protective immunity against myonecrosis

Vaccine

Volumn 30, Issue 37, 2012, Pages 5500-5505

  Frey, Joachim ^a   Johansson, Anders ^a   Bürki, Sibylle ^a,c   Vilei, Edy M ^a,d   Redhead, Keith ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Walton Manor   (United Kingdom)

^c NATIONAL FOOD ADMINISTRATION   (Sweden)

^d Suisselab AG   (Switzerland)

Author keywords

Black leg; Leucocidin; Pore forming toxin; Protective immunity

Indexed keywords

BACTERIAL TOXIN; BACTERIAL VACCINE; CLOSTRIDIUM CHAUVOEI TOXIN A; CLOSTRIDIUM CHAUVOEI VACCINE; HYBRID PROTEIN; NUSA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GENOME; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CLOSTRIDIUM CHAUVOEI; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; ESCHERICHIA COLI; GENE EXPRESSION; GENOME ANALYSIS; GUINEA PIG; HEMOLYSIS; MOLECULAR CLONING; MUSCLE NECROSIS; NONHUMAN; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VACCINATION;

ANIMALS; BACTERIAL TOXINS; BACTERIAL VACCINES; CATTLE; CLONING, MOLECULAR; CLOSTRIDIUM CHAUVOEI; CLOSTRIDIUM INFECTIONS; CYTOTOXINS; GENOME, BACTERIAL; GUINEA PIGS; HEMOLYTIC AGENTS; MOLECULAR SEQUENCE DATA; MUSCLES; NECROSIS; NEUTRALIZATION TESTS; PHYLOGENY; RABBITS; RECOMBINANT PROTEINS; VIRULENCE FACTORS;

EID: 84864309478     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.050     Document Type: Article

References (43)

1. The pathogenic anaerobia bacteria. Clostridium chauvoei 1984, 164-179. Springfield, Illinois, USA. 3rd ed. L.D. Smith, B.L. Williams, C.C. Thomas (Eds.).
2. Groseth P.K., Ersdal C., Bjelland A.M., Stokstad M. Large outbreak of blackleg in housed cattle. Vet Rec 2011, 169(13):339.
3. Nagano N., Isomine S., Kato H., et al. Human fulminant gas gangrene caused by Clostridium chauvoei. J Clin Microbiol 2008, 46(4):1545-1547.
4. Weatherhead J.E., Tweardy D.J. Lethal human neutropenic entercolitis caused by Clostridium chauvoei in the United States: tip of the iceberg?. J Infect 2012, 64(2):225-227.
5. Hatheway C.L. Toxigenic clostridia. Clin Microbiol Rev 1990, 3:66-98.
6. Songer J.G. Clostridial enteric diseases of domestic animals. Clin Microbiol Rev 1996, 9:216-234.
7. Useh N.M., Nok A.J., Esievo K.A. Pathogenesis and pathology of blackleg in ruminants: the role of toxins and neuraminidase. A short review. Vet Q 2003, 25(4):155-159.
8. Uzal F.A. Evidence-based medicine concerning efficacy of vaccination against Clostridium chauvoei infection in cattle. Vet Clin North Am Food Anim Pract 2012, 28(1):71-77.
9. Claus K.D., Macheak M.E. Preparation of a Clostridium chauvoei antigen and determination of protective immunity by plate agglutination test. Am J Vet Res 1972, 33(5):1045-1052.
10. Kerry J.B., Craig G.R. Field studies in sheep with multicomponent clostridial vaccines. Vet Rec 1979, 105(24):551-554.
11. Chandler H.M., Gulasekharam J. The protective antigen of a highly immunogenic strain of Clostridium chauvoei including an evaluation of its flagella as a protective antigen. J Gen Microbiol 1974, 84(1):128-134.
12. Tamura Y., Kijima-Tanaka M., Aoki A., Ogikubo Y., Takahashi T. Reversible expression of motility and flagella in Clostridium chauvoei and their relationship to virulence. Microbiology 1995, 141(Pt 3):605-610.
13. Tanaka M., Hirayama N., Tamura Y. Production, characterization, and protective effect of monoclonal antibodies to Clostridium chauvoei flagella. Infect Immun 1987, 55:1779-1783.
14. Useh N.M., Ajanusi J.O., Esievo K.A., Nok A.J. Characterization of a sialidase (neuraminidase) isolated from Clostridium chauvoei (Jakari strain). Cell Biochem Funct 2006, 24(4):347-352.
15. Verpoort J.A., Joubert F.J., Jansen B.C. Studies on the soluble antigen and hemolysin of Clostridium chavoei strain 64. S Afr J Agric Sci 1966, 9:153-172.
16. Hang'ombe B.M., Kohda T., Mukamoto M., Kozaki S. Purification and sensitivity of Clostridium chauvoei hemolysin to various erythrocytes. Comp Immunol Microbiol Infect Dis 2006, 29(4):263-268.
17. Vilei E.M., Johansson A., Schlatter Y., Redhead K., Frey J. Genetic and functional characterization of the NanA sialidase from Clostridium chauvoei. Vet Res 2011, 42(1):2.
18. Pitcher D.G., Saunders N.A., Owen R.J. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 1989, 8:151-156.
19. Current protocols in molecular biology 1999, John Wiley & Sons, Inc., New York. F.M. Ausubel, R. Brent, R.E. Kingston, F.M. Ausubel, R. Brent, R.E. Kingston (Eds.).
20. Besemer J., Lomsadze A., Borodovsky M. GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. implications for finding sequence motifs in regulatory regions. Nucleic Acids Res 2001, 29(12):2607-2618.
21. Bendtsen J.D., Nielsen H., von Heijne G., Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340(4):783-795.
22. Gardy J.L., Laird M.R., Chen F., et al. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2005, 21:617-623.
23. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22(22):4673-4680.
24. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997, 25(24):4876-4882.
25. Page R.D. TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996, 12(4):357-358.
26. Gibert M., Jolivet-Reynaud C., Popoff M.R., Jolivet-Renaud C. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene 1997, 203(1):65-73.
27. Schaller A., Kuhn R., Kuhnert P., et al. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology 1999, 145:2105-2116.
28. Pilo P., Vilei E.M., Peterhans E., et al. A metabolic enzyme as a primary virulence factor of Mycoplasma mycoides subsp. mycoides small colony. J Bacteriol 2005, 187(19):6824-6831.
29. Frey J., Nicolet J. Purification and partial characterization of a hemolysin produced by Actinobacillus pleuropneumoniae type strain 4074. FEMS Microbiol Lett 1988, 55:41-46.
30. Altschul S.F., Madden T.L., Schäffer A.A., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25(17):3389-3402.
31. Szafron D., Lu P., Greiner R., et al. Proteome analyst: custom predictions with explanations in a web-based tool for high-throughput proteome annotations. Nucleic Acids Res 2004, 32(Web Server issue):W365-W371.
32. Skarin H., Hafstrom T., Westerberg J., Segerman B. Clostridium botulinum group III: a group with dual identity shaped by plasmids, phages and mobile elements. BMC Genomics 2011, 12:185.
33. Keyburn A.L., Boyce J.D., Vaz P., et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog 2008, 4(2):e26.
34. Hunter S.E., Brown J.E., Oyston P.C., Sakurai J., Titball R.W. Molecular genetic analysis of beta-toxin of Clostridium perfringens reveals sequence homology with alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus. Infect Immun 1993, 61:3958-3965.
35. Ivanova N., Sorokin A., Anderson I., et al. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature 2003, 423(6935):87-91.
36. Song L., Hobaugh M.R., Shustak C., Cheley S., Bayley H., Gouaux J.E. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 1996, 274(5294):1859-1866.
37. Hammarström M., Hellgren N., van den Berg S., Berglund H., Härd T. Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli. Protein Sci 2002, 11(2):313-321.
38. Nagahama M., Kihara A., Miyawaki T., et al. Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity. Biochim Biophys Acta 1999, 1454(1):97-105.
39. Steinthorsdottir V., Fridriksdottir V., Gunnarsson E., Andresson O.S. Site-directed mutagenesis of Clostridium perfringens beta-toxin: expression of wild-type and mutant toxins in Bacillus subtilis. FEMS Microbiol Lett 1998, 158(1):17-23.
40. Walker B., Bayley H. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. J Biol Chem 1995, 270(39):23065-23071.
41. Walker B., Bayley H. Restoration of pore-forming activity in staphylococcal alpha-hemolysin by targeted covalent modification. Protein Eng 1995, 8:491-495.
42. Popoff M.R., Bouvet P. Clostridial toxins. Future Microbiol 2009, 4(8):1021-1064.
43. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.